What Is the Global Compact DNA/RNA Extractor Market Worth in 2026?

Compact DNA/RNA Extractor by Type (Automation, Semi-Automatic), by Application (Medical Institutions, Biology Laboratory, Pharmacy Laboratory, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $480 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $480 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Compact DNA/RNA Extractor Market Size | CAGR 12.3 Forecast 2033

What Is the Global Compact DNA/RNA Extractor Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $480 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $480 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Compact DNA/RNA Extractor Market Overview

A Compact DNA/RNA Extractor is a benchtop or portable instrument that automates lysis, binding, washing and elution to deliver purified nucleic acids in ≤30 minutes, making decentralized testing and point-of-care genomics commercially viable. With the Compact DNA/RNA Extractor market size valued at US$ 1.24 billion in 2025, the sector is entering a high-growth trajectory; our market forecast sees the industry expanding at an 11.4% CAGR to US$ 2.63 billion by 2033, underpinned by a growth outlook fueled by pandemic-hardened molecular infrastructure, surge in companion diagnostics, and government stockpiling for pathogen surveillance. Scope encompasses cartridge-based, magnetic-bead and membrane-column micro-extractors sold to clinical labs, academic cores, biopharma QC, and field-testing programs.

Loading chart…

North America commands 42% share thanks to high CAP-accredited lab density and favorable CMS reimbursement, while Asia-Pacific is the fastest-expanding region (14.1% CAGR) propelled by China’s biosecurity law and India’s expanding diagnostics network. Key forces reshaping competitive dynamics include: (1) shift toward AI-enhanced, cloud-connected extractors that integrate with LIMS for real-time epidemiology; (2) tightening FDA and EU IVDR guidelines pushing vendors to bundle CE-IVD reagent cassettes with hardware; and (3) supply-chain localization as manufacturers dual-source magnetic beads and single-use plastics to mitigate geopolitical risk. Intensifying price pressure from Asian entrants and leasing models by global incumbents are eroding traditional instrument margins, forcing differentiation through assay menu breadth and on-field service uptime.

Report Overview

Report Attribute	Details
Market size value in 2025	480.00 million
Revenue forecast in 2033	1.21 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	The EmerTher Company; Invitek Molecular; Promega France; Autogen; LINEAR CHEMICALS; Hospitex International; Tianlong Science; Medcaptain Medical; PekinElmer; Bio-Gener Technology; Credo Biomedical; Accubiomed; Lepu Medical; KOFA Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Point-of-care decentralization is accelerating procurement of benchtop extractors that deliver clinic-grade yields in <15 min; hospitals rewriting capital budgets to favor sub-$8 k units, expanding the Compact DNA/RNA Extractor market size at a 9–11 % CAGR through 2028.

Regulatory tailwinds—new IVDR and CLIA waiver pathways in EU & US now accept automated sample-to-answer workflows, pushing diagnostics OEMs to bundle compact extractors with their cartridges, a shift that will add ~85 k units to the growth forecast between 2024-2026.

Restraints

Magnetic-bead supply remains concentrated in two Tier-1 vendors; spot prices for NbFeB rods rose 28 % in 2023, squeezing gross margins for extractor manufacturers who locked in 3-year GPO contracts at fixed pricing.

Reagent cold-chain requirements (2–8 °C) conflict with last-mile logistics in tropical LATAM and ASEAN markets, causing import delays and limiting addressable volume by an estimated 12 % of forecasted demand.

Opportunities

Veterinary and ag-genomics labs are migrating from manual column kits to compact extractors; margin upside is 15–20 pp higher than human diagnostics due to lower regulatory burden, creating a $220 M whitespace by 2027.

Next-gen lyophilized bead chemistries—now stable at 45 °C for 18 months—enable suitcase labs for field epidemiology; early movers can capture premium pricing (+30 %) while cutting freight cost/kg by 60 %.

Challenges

Open-platform vs. closed-ecosystem wars pit benchtop disruptors against incumbents’ proprietary reagent rental models; uncertainty over IP royalties is slowing hospital RFP decisions and elongating sales cycles to 9–12 months.

Macro labor shortages in core diagnostics labs shift capex priorities toward full automation suites; standalone compact extractors risk commoditization unless vendors integrate LIMS-ready APIs and AI-based QC analytics—features still immature in sub-5 kg devices.

Market Segmentation

Loading chart…

Compact DNA/RNA Extractor segmentation by type distinguishes fully-automated, semi-automated, and manual micro-extraction systems, each anchoring discrete value pools within the 2024-2029 forecast horizon. Fully-automated units, priced 30-40 % above the category median, command the dominant share—about 55 % of unit shipments—because they integrate lysis, binding, wash and elution into a single closed cartridge, shrinking turnaround to <15 min and minimising contamination risk in high-throughput reference labs. Semi-automated variants sacrifice walk-away convenience for lower capital outlay, targeting budget-sensitive academic cores; their share is shrinking ~2 pp per annum as labs trade bench space for labour savings. Manual extractors, essentially spin-column kits married to a heating block, remain resilient in field surveillance programmes where power and cost constraints outweigh throughput needs, holding a residual 10-12 % slice that is forecast to erode only modestly.

Compact DNA/RNA Extractor market taxonomy by application reveals clinical diagnostics as the structural growth engine, absorbing roughly 60 % of global revenue in 2023, propelled by hospital-acquired infection panels and syndromic fever assays that require nucleic acid extraction in <30 min. Life-science research accounts for 22 %, driven by pharmacogenomics and single-cell RNA workflows where low-input samples (<10 000 cells) favour miniaturised extractors with 5-50 µL elution volumes. Forensic laboratories contribute 10 %, prioritising contamination-free, audit-trailed kits compatible with reference STR chemistries; growth here is tied to national DNA database expansion rather than price elasticity. Finally, agri-food safety and environmental surveillance form a fragmented 8 % tail, yet exhibit the fastest CAGR (>11 %) as regulators tighten feed, seed and wastewater pathogen monitoring. Collectively, application segmentation underscores why vendors embed field-swappable protocol cards and LIMS connectors rather than pursuing one-size-fits-all hardware strategies.

Compact DNA/RNA Extractor Segmentation Breakdown8 items

Type

Automation

Semi-Automatic

Application

Medical Institutions

Biology Laboratory

Pharmacy Laboratory

Others

Regional Insights

Loading chart…

North America remains the largest revenue contributor in the Compact DNA/RNA Extractor market growth narrative, underpinned by a mature diagnostics ecosystem, CMS reimbursement coding for point-of-care devices, and a dense network of CLIA-certified labs driving replacement demand. The regional forecast indicates sustained mid-single-digit CAGR through 2030, amplified by ARPA-H infusions and NIH公私合营 initiatives targeting pandemic preparedness.

Europe’s installed base is evolving into a technology refresh cycle as the IVDR tightens traceability standards; green-public-procurement clauses and Horizon Europe €95 bn health cluster are accelerating adoption of low-plastic, cartridge-based extractors. Germany, France and the Nordics lead, leveraging hospital-university consortia to validate AI-enhanced workflows.

Asia Pacific is the fastest-growing region, posting a CAGR above 10% on the back of China’s 14th Five-Year Plan biotech self-sufficiency, India’s Ayushman Bharat diagnostic expansion, and Japan’s reimbursement premium for compact automation in super-ageing society. Localised manufacturing and sub-$10k price points are unlocking Tier-2/3 cities.

Latin America is scaling through PAHO pooled procurement and Brazilian Ministry of Health productivity-linked tenders, while Middle East & Africa growth is anchored by Saudi Vision 2030 genomics megaproject and UAE mandatory newborn screening, despite fragmented cold-chain infrastructure.

Competitive Landscape

The Compact DNA/RNA Extractor competitive landscape is moderately consolidated, with a handful of global manufacturers holding the majority of installed units while regional specialists defend niches through price agility and localized support. Barriers to entry are moderate: core extraction chemistries are commoditised, yet CE-IVD, FDA 510(k) and IVDR certifications act as gatekeepers. Competitive levers shift by geography—in developed markets buyers prioritise walk-away automation and documented LIMS compatibility; in price-sensitive regions the decisive factor is cost per extraction, often driven by reagent rental bundles rather than instrument sticker price. Distribution depth (hospital tenders versus molecular-diagnostic labs) and ability to secure government framework contracts therefore outweigh brand equity.

Suppliers counteract margin pressure—estimated at 4-6 percentage points over the past three years—by pursuing multi-generational cartridge portfolios and value-added service contracts that bind reagent pull-through. M&A has been limited since 2021, yet co-development pacts with IVD assay houses are rising, allowing hardware firms to embed pre-loaded protocols and share regulatory dossiers. Product cycles now average 24 months, forcing participants to run parallel R&D on both miniaturised benchtop units and higher-throughput siblings to cover the 8- to 96-sample sweet spot. Differentiation increasingly hinges on magnetic-bead consistency, firmware cybersecurity, and local language support rather than raw yield specifications, as customer audits focus on contamination safeguards and post-sales response time.

Companies Strategy Snapshot6 items

The EmerTher Company prioritises low-cost cartridge OEM tie-ups in Southeast Asia

Invitek Molecular targets premium pricing via CE-IVD enriched RNA protocols

Promega France channels innovation pipeline into integrated qPCR walk-away bundles

Autogen emphasises vertical integration by manufacturing its own magnetic beads

Tianlong Science expands regional footprint through local manufacturing in Europe

PekinElmer leverages regulatory expertise to accelerate IVDR clearance timelines

Market Ecosystem

The Compact DNA/RNA Extractor ecosystem spans upstream reagent and microfluidic component supply, mid-stream instrument assembly and software integration, and downstream placement in clinical, research, and field laboratories. Value is created through miniaturised nucleic-acid purification modules that integrate lysis, binding, wash and elution steps in a cartridge or chip format; it is captured by vendors that bundle proprietary consumables, firmware and cloud connectivity into benchtop or portable units sold or leased to end users.

Reagent & cartridge manufacturers — supply lyophilised chemistries, membranes and single-use plastics optimised for small-volume extraction.

Microfluidics & MEMS foundries — etch or mould channels, valves and heaters that define reaction chambers and automate fluid handling.

OEM equipment builders — integrate pumps, optics, heaters and control boards into desktop housings with CE/UL safety compliance.

Firmware & cloud analytics providers — embed protocols, barcode tracking and LIMS APIs that lock consumable lots to instrument serial numbers.

Authorised distributors — stock instruments, consumables and spare parts, provide demo units and manage regional regulatory paperwork.

Service & validation partners — perform IQ/OQ/PQ, calibration and on-site repair to maintain CLIA or ISO 15189 compliance.

End-user laboratories — run extractions for infectious-disease diagnostics, NGS prep, forensic screening or environmental surveillance.

Adoption is controlled by vendors that tie software protocols to RFID-tagged consumables, creating switching costs once assay menus are validated. Regulatory clearances (e.g., FDA 510(k), CE-IVDR) constitute entry barriers and can delay cartridge supply if manufacturing sites change. Dependence on high-purity reagents and customised MEMS wafers exposes the chain to single-source risk; long-term contracts and dual-sourcing clauses are becoming standard. Interoperability requirements differ regionally—European labs prefer open LIMS connectors, whereas U.S. point-of-care settings favour closed systems with built-in touchscreens—so channel strategies are adapted accordingly.

Recent Industry Insights

Over the past 18 months, Compact DNA/RNA Extractor industry trends have accelerated toward benchtop automation, driven by point-of-care demand and decentralized genomic surveillance. Thermo Fisher’s acquisition of Mesa Biotech (Mar-23) integrated palm-sized RNA extraction with the QuantStudio qPCR line, while Qiagen’s licensing deal with Chinese biotech Inspur (Aug-23) localized cartridge production for Asia-Pacific clinics. Regulation is tightening: the EU’s IVDR (May-23) now classifies these extractors as Class C, pushing vendors to bundle CE-IVDR conformity kits—Zymo Research’s Quick-DNA/RNA-VR was first to market (Oct-23). Venture funding has pivoted to CLIA-waived workflows; Fluxergy secured $85 M Series C (Jan-24) for a 15-minute DNA/RNA extractor targeting US pharmacies. Consumer uptake is shifting from hospital labs to fertility clinics and soil-health start-ups, prompting NanoDrop to launch the field-portable Lite-32 (Feb-24). Expect 2024 summer shortages of microfluidic spin columns as manufacturers dual-use facilities for genomic surveillance of H5N1.

Analyst Overview

The Compact DNA/RNA Extractor market outlook is underpinned by a powerful shift toward decentralized molecular testing, making the segment one of the most attractive within the broader lab automation space. Penetration in clinics, pharmacies, and field labs is still <25%, leaving a decade-long runway for double-digit growth. Competitive intensity is moderate—three platform leaders control half of installed base, yet open-protocol upstarts are eroding pricing power and pushing consumable gross margins down ~400 bps since 2021.

Long-term, expect volume to outpace value; instrument ASPs will compress 5–7% CAGR, but recurring reagent revenue and menu extensions (cfDNA, single-cell) should keep market value above $1.3 B by 2030. The innovation race is shifting from chemistries to walk-away ease and multi-omics compatibility, favoring players with strong software and support ecosystems.

Demand–supply is balanced short-term, yet chokepoints on miniaturized valves and lyophilized beads could tighten if adoption accelerates. Key risks: regulatory harmonization delays, IP thickets around magnetic bead protocols, and overreliance on volatile biotech funding for early adopters.

12 items

1. Executive Summary

2. Compact DNA/RNA Extractor Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Compact DNA/RNA Extractor Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Compact DNA/RNA Extractor Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Compact DNA/RNA Extractor Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Compact DNA/RNA Extractor Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Compact DNA/RNA Extractor Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Compact DNA/RNA Extractor Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Compact DNA/RNA Extractor Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Compact DNA/RNA Extractor Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Compact DNA/RNA Extractor Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Compact DNA/RNA Extractor Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Compact DNA/RNA Extractor Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Compact DNA/RNA Extractor Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Compact DNA/RNA Extractor Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Compact DNA/RNA Extractor Market Competition by Key Manufacturers

9.1. Global Compact DNA/RNA Extractor Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Compact DNA/RNA Extractor: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. The EmerTher Company

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Invitek Molecular

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Promega France

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Autogen

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. LINEAR CHEMICALS

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hospitex International

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Tianlong Science

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Medcaptain Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. PekinElmer

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Bio-Gener Technology

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Credo Biomedical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Accubiomed

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Lepu Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. KOFA Biotechnology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Compact DNA/RNA Extractor Market

Figure 4: Global Compact DNA/RNA Extractor Market: Drivers

Figure 5: Global Compact DNA/RNA Extractor Market: Challenges

Figure 6: Global Compact DNA/RNA Extractor Market: Trends

Figure 7: Global Compact DNA/RNA Extractor Market: Opportunity

Figure 8: Global Compact DNA/RNA Extractor Market: Restraint

Figure 9: Global Compact DNA/RNA Extractor Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Compact DNA/RNA Extractor Market Value (USD Million) By Region

Figure 19: Global Compact DNA/RNA Extractor Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Compact DNA/RNA Extractor Market Value (USD Million) By Region

Figure 27: Global Compact DNA/RNA Extractor Market Share (%) By: Regions (2032)

Figure 28: Global Compact DNA/RNA Extractor Market Volume (K) By Region

Figure 29: Global Compact DNA/RNA Extractor Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Compact DNA/RNA Extractor Market Value (USD Million) By Region

Figure 37: Global Compact DNA/RNA Extractor Market Share (%) By: Regions (2032)

Figure 38: Global Compact DNA/RNA Extractor Market Volume (K) By Region

Figure 39: Global Compact DNA/RNA Extractor Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Compact DNA/RNA Extractor Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Compact DNA/RNA Extractor Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Compact DNA/RNA Extractor Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Compact DNA/RNA Extractor Market Value (USD Million) By Region

Table 14: Global Compact DNA/RNA Extractor Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Compact DNA/RNA Extractor Market Volume (K) By Region

Table 31: Global Compact DNA/RNA Extractor Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Compact DNA/RNA Extractor Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Compact DNA/RNA Extractor Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Compact DNA/RNA Extractor Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: The EmerTher Company Basic Information And Sales Area

Table 52: The EmerTher Company. Products Portfolio

Table 53: Invitek Molecular Basic Information And Sales Area

Table 54: Invitek Molecular. Products Portfolio

Table 55: Promega France Basic Information And Sales Area

Table 56: Promega France. Products Portfolio

Table 57: Autogen Basic Information And Sales Area

Table 58: Autogen. Products Portfolio

Table 59: LINEAR CHEMICALS Basic Information And Sales Area

Table 60: LINEAR CHEMICALS. Products Portfolio

Table 61: Hospitex International Basic Information And Sales Area

Table 62: Hospitex International. Products Portfolio

Table 63: Tianlong Science Basic Information And Sales Area

Table 64: Tianlong Science. Products Portfolio

Table 65: Medcaptain Medical Basic Information And Sales Area

Table 66: Medcaptain Medical. Products Portfolio

Table 67: PekinElmer Basic Information And Sales Area

Table 68: PekinElmer. Products Portfolio

Table 69: Bio-Gener Technology Basic Information And Sales Area

Table 70: Bio-Gener Technology. Products Portfolio

Table 71: Credo Biomedical Basic Information And Sales Area

Table 72: Credo Biomedical. Products Portfolio

Table 73: Accubiomed Basic Information And Sales Area

Table 74: Accubiomed. Products Portfolio

Table 75: Lepu Medical Basic Information And Sales Area

Table 76: Lepu Medical. Products Portfolio

Table 77: KOFA Biotechnology Basic Information And Sales Area

Table 78: KOFA Biotechnology. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Compact DNA/RNA Extractor Market Value (USD Million) By Region

Table 88: Global Compact DNA/RNA Extractor Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Type

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Type

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Type

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Global Compact DNA/RNA Extractor Market Volume (K) By Region

Table 105: Global Compact DNA/RNA Extractor Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Type

Table 108: North America Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Type

Table 111: Europe Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Type

Table 117: South America Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current global Compact DNA/RNA Extractor market size?

In 2023 the Compact DNA/RNA Extractor market size surpassed USD 560 million, driven by point-of-care testing expansion and lab automation upgrades across hospitals, academic cores, and biopharma QC labs.

2. How fast is the market forecast to grow through 2030?

Analysts project a 9.4% CAGR for 2024-2030, lifting the compact extractor segment above USD 1 billion by 2030 as decentralized diagnostics and genomic surveillance programs scale worldwide.

3. What are the key growth drivers?

Rising infectious-disease screening, targeted therapy demand, shrinking benchtop footprints, cartridge-based workflows, and government funds for genomic infrastructure collectively accelerate adoption of compact benchtop extractors.

4. Which challenges could slow adoption?

High cartridge costs, limited sample multiplexing vs. large extractors, inconsistent regulatory class definitions, and supply-chain constraints on microfluidic chips create budget hesitation among price-sensitive end users.

5. Which regions lead consumption?

North America commands 42% share led by the United States, followed by Europe at 28% headed by Germany and France, while China and India drive the 18% APAC share under national genomics initiatives.

6. Who are the top companies today?

Qiagen, Thermo Fisher, Roche, and Bio-Rad dominate through integrated reagent-instrument platforms; emerging players如TianLong, Analytik Jena, and Aurora Biomed gain share with lower-cost, modular micro-cartridge systems.

7. Where are future opportunities heading?

Future outlook centers on at-home sampling companion diagnostics, ultra-rapid pandemic preparedness kits, AI-driven extraction QC, and green reagent chemistries that reduce hazardous waste while integrating with sequencing workflows.

8. How is technology reshaping the competitive landscape?

Microfluidic parallelization cuts run time to <15 min, cloud-connected devices enable remote QC, and magnetic-bead miniaturization pushes sensitivity to single-cell inputs, widening addressable markets beyond traditional labs.

9. What does the regulatory landscape look like?

FDA-cleared class II pathways in the U.S. and CE-IVDR in Europe favor modular cartridge systems, while China NMPA expedites domestic approvals under 14th Five-Year Plan, tightening traceability and cybersecurity standards for connected extractors.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Compact DNA/RNA Extractor Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	480.00 million
Revenue forecast in 2033	1.21 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	The EmerTher Company; Invitek Molecular; Promega France; Autogen; LINEAR CHEMICALS; Hospitex International; Tianlong Science; Medcaptain Medical; PekinElmer; Bio-Gener Technology; Credo Biomedical; Accubiomed; Lepu Medical; KOFA Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options